The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers
Trial registered on ANZCTR


Registration number
Help: Registration number
ACTRN12626000547347
Ethics application status
Help: Ethics application status
Approved
Date submitted
Help: Date submitted
8/04/2026
Date registered
Help: Date registered
30/04/2026
Date last updated
Help: Date last updated
28/08/2026
Date data sharing statement initially provided
Help: Data sharing statement date
30/04/2026
Type of registration
Help: Type of registration
Prospectively registered

Titles & IDs
Public title
Identifying brain activity that predicts postoperative delirium in older adults undergoing anaesthesia and surgery
Scientific title
Identifying electroencephalogram (EEG) biomarkers that predict postoperative delirium in older adults undergoing anaesthesia and surgery
Additional trial identifiers [1] 316356 0
None
Universal Trial Number (UTN)
Trial acronym
MEG POD
Related trial records

Health condition
Health condition(s) studied:
Postoperative delirium 340429 0
Condition category
Condition code
Anaesthesiology 336639 336639 0 0
Anaesthetics
Neurological 336640 336640 0 0
Other neurological disorders

Intervention/exposure
Study type
Observational
Patient registry
False
Target follow-up duration
Target follow-up type
Description of the intervention or exposure
This observational study is primarily aimed at observing the incidence of postoperative delirium and correlating this with changes in the multichannel EEG. The population of patients are those already scheduled for anaesthesia and surgery. Most assessments (excluding a pre admission and 3 month follow up cognition assessment by phone) will occur during the subjects usual hospital stay.

The multichannel EEG will be recorded at multiple timepoints - preoperative, intraoperative (induction, maintenance, emergence), and the postoperative anaesthetic care unit (PACU)

Postoperative delirium assessments will occur preoperatively and twice daily until day 3 postoperatively

As a secondary outcome, blood based biomarkers (neural injury and inflammatory) will be obtained at baseline and postoperative day 1 and 2. Cognition assessments will also be performed prior to admission and at 3 month follow up.

Participant time commitment likely to be:
Pre-admission cognition assessment (telephone) - 30minutes
Fitting of EEG recording equipment prior to surgery - 20 minutes
Postoperative delirium assessments - 2 to 10 minutes for each assessment (twice daily until postoperative day 3)
Final 3 month follow up cognition assessment (telephone) - 30 minutes
Intervention code [1] 333016 0
Diagnosis / Prognosis
Description of the comparator or control
No control group
Control group
Uncontrolled

Outcomes
Primary outcome [1] 345002 0
Postoperative Delirium
Timepoint [1] 345002 0
PACU assessment and postoperative days 1 - 5
Primary outcome [2] 345191 0
EEG-derived biomarkers of postoperative delirium risk
Timepoint [2] 345191 0
Preoperative (baseline), intraoperative (induction, maintenance and emergence) and in the postoperative care unit (PACU)
Secondary outcome [1] 460092 0
Modified Telephone Interview for Cognitive Status (TICS-M)
Timepoint [1] 460092 0
Preadmission and 3 months postoperative
Secondary outcome [2] 460093 0
Euroqol 5 Dimension 5 Level (EQ-5D-5L)
Timepoint [2] 460093 0
Preadmission and 3 months postoperative
Secondary outcome [3] 460834 0
Blood based biomarkers of cognition
Timepoint [3] 460834 0
Preoperative (baseline) and postoperative days 1 and 2 (3 timepoints in total)
Secondary outcome [4] 460835 0
Geriatric Depression Scale (GDS)
Timepoint [4] 460835 0
Pre admission and 3 month follow up
Secondary outcome [5] 460836 0
Verbal fluency
Timepoint [5] 460836 0
Preadmission and 3 month follow up
Secondary outcome [6] 460837 0
Subjective memory complaint
Timepoint [6] 460837 0
Preadmission and 3 month follow up

Eligibility
Key inclusion criteria
Age > 65 years receiving general anaesthesia (propofol or sevoflurane) for an elective surgical procedure
Sufficient English language proficiency to complete cognitive assessments (as assessed by research team)
Surgical procedure > 2 hour duration (and = 2-night stay)
American Society of Anaesthetists (ASA) Grade I - III
Minimum age
65 Years
Maximum age
No limit
Sex
Both males and females
Healthy volunteers
No
Key exclusion criteria
Positive screen for delirium on day of surgery (3D CAM assessment)
Cardiac, intracranial surgery or other surgery involving the scalp
ASA IV

Study design
Purpose
Screening
Duration
Longitudinal
Selection
Defined population
Timing
Prospective
Statistical methods / analysis
To estimate the required number of participants we have used a currently described method of POD risk stratification, mean alpha power during anaesthesia, as a benchmark. Our own systematic review of observational studies indicates that the estimated mean difference between POD and non-POD participants in mean alpha power is 1.8dB.

The estimated population standard deviation for alpha power is reported as 2.1dB. We assume for the purposes of the sample size estimation that the incidence of POD in our cohort will be approximately 20%.

To identify a difference of 1.8dB between two independent populations, and assuming a ratio of four participants who do not develop POD for each one who does (incidence of POD of 20%), with a power of 80% and significance of 0.05, we will require 70 participants (Stata/IC 17.0, power twomeans).

Allowing for a 10% rate of data loss (either at data collection or follow-up phase), we will aim to recruit 77 participants.

Recruitment
Recruitment status
Recruiting
Date of first participant enrolment
Anticipated
Actual
Date of last participant enrolment
Anticipated
Actual
Date of last data collection
Anticipated
Actual
Sample size
Target
Accrual to date
Final
Recruitment in Australia
Recruitment state(s)
VIC
Recruitment hospital [1] 29371 0
St Vincent's Hospital (Melbourne) Ltd - Fitzroy
Recruitment postcode(s) [1] 45689 0
3065 - Fitzroy

Funding & Sponsors
Funding source category [1] 320959 0
Charities/Societies/Foundations
Name [1] 320959 0
ANZCA Foundation
Country [1] 320959 0
Australia
Funding source category [2] 321575 0
Hospital
Name [2] 321575 0
St. Vincent's Hospital Melbourne
Country [2] 321575 0
Australia
Primary sponsor type
Hospital
Name
St. Vincent's Hospital Melbourne
Address
Country
Australia
Secondary sponsor category [1] 324370 0
None
Name [1] 324370 0
Address [1] 324370 0
Country [1] 324370 0

Ethics approval
Ethics application status
Approved
Ethics committee name [1] 319498 0
St Vincent's Hospital Melbourne Human Research Ethics Committee
Ethics committee address [1] 319498 0
Ethics committee country [1] 319498 0
Australia
Date submitted for ethics approval [1] 319498 0
12/01/2026
Approval date [1] 319498 0
02/04/2026
Ethics approval number [1] 319498 0

Summary
Brief summary
Trial website
Trial related presentations / publications
Public notes

Contacts
Principal investigator
Name 147518 0
Dr Steven McGuigan
Address 147518 0
St. Vincent's Hospital Melbourne, 41 Victoria Parade, Fitzroy, Victoria, 3065
Country 147518 0
Australia
Phone 147518 0
+61 3 9231 4253
Fax 147518 0
Email 147518 0
Contact person for public queries
Name 147519 0
Steven McGuigan
Address 147519 0
St. Vincent's Hospital Melbourne, 41 Victoria Parade, Fitzroy, Victoria, 3065
Country 147519 0
Australia
Phone 147519 0
+61 3 9231 4253
Fax 147519 0
Email 147519 0
Contact person for scientific queries
Name 147520 0
Steven McGuigan
Address 147520 0
St. Vincent's Hospital Melbourne, 41 Victoria Parade, Fitzroy, Victoria, 3065
Country 147520 0
Australia
Phone 147520 0
+61 3 9231 4253
Fax 147520 0
Email 147520 0

Data sharing statement
Will the study consider sharing individual participant data?
Yes
Will there be any conditions when requesting access to individual participant data?
Persons/groups eligible to request access:
• Researchers
Conditions for requesting access:
• Yes, conditions apply:
• Requires review on a case-by-case basis by the trial custodian, sponsor or data sharing committee
• Requires a scientifically sound proposal or protocol
• Requires a data sharing agreement between data requester and trial custodian or sponsor
What individual participant data might be shared?
• De-identified individual participant data:
• All outcomes data
• Published results
• Primary outcome(s)
• Safety data
What types of analyses could be done with individual participant data?
• Only those analyses approved by study investigators

When can requests for individual participant data be made (start and end dates)?
From:
At the end of the study
To:
No end date
Where can requests to access individual participant data be made, or data be obtained directly?
• Email of trial custodian, sponsor or committee: [email protected]

Are there extra considerations when requesting access to individual participant data?
No


What supporting documents are/will be available?

No Supporting Document Provided


Results publications and other study-related documents

Documents added manually
No documents have been uploaded by study researchers.

Documents added automatically
No additional documents have been identified.